Screening tests for active pulmonary tuberculosis in childre | Figure 1

%27%3e%3cg%20id=%27Group-14%27%20transform=%27translate(13.000000,%20103.176124)%27%3e%3cg%20id=%27Group-Copy-5%27%20transform=%27translate(0.000000,%20182.676124)%27%3e%3crect%20id=%27Rectangle-8%27%20fill=%27%23E2E0DE%27%20x=%270%27%20y=%270%27%20width=%2736%27%20height=%2736%27%20rx=%2718%27%3e%3c/rect%3e%3cpath%20d=%27M28,27.6503435%20C28,22.127496%2023.5228474,17.6503435%2018,17.6503435%20C12.4771525,17.6503435%208,22.127496%208,27.6503435%20M18,16.3472505%20C20.8165136,16.3472505%2023.099749,14.0640151%2023.099749,11.2475015%20C23.099749,8.43098783%2020.8165136,6.1477524%2018,6.1477524%20C15.1834863,6.1477524%2012.9002509,8.43098783%2012.9002509,11.2475015%20C12.9002509,14.0640151%2015.1834863,16.3472505%2018,16.3472505%20Z%27%20id=%27Combined-Shape%27%20fill=%27%23FFFFFF%27%20fill-rule=%27nonzero%27%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)

Deleted account

Some actions are only available when you log in.

Report case

Report this to our moderators

Screening tests for active pulmonary tuberculosis in children

You can view up to 4 cases without signing up Sign up for unlimited access

Why is improving screening for pulmonary tuberculosis in children important?

Tuberculosis is one of the leading causes of death worldwide. Most children who die from tuberculosis are never diagnosed or treated. Screening may be useful to identify children with possible tuberculosis and refer them for further testing. As well, screening could be used to identify children without tuberculosis, who should be considered for preventive treatment. A false‐positive result means that children may undergo unnecessary testing and treatment and may not receive preventive treatment promptly. A false‐negative result means that children have tuberculosis, but may miss further testing to confirm the diagnosis.

What is the aim of this review?

To determine the accuracy of screening tests for active pulmonary tuberculosis in children in high‐risk groups, such as children with HIV and close contacts of people with tuberculosis.

What was studied in this review?

Screening tests were: one tuberculosis symptom; one or more of a combination of tuberculosis symptoms; the World Health Organization (WHO) four‐symptom screen (one or more of cough, fever, poor weight gain, or tuberculosis contact) in children with HIV, recommended at each healthcare visit; chest radiography (CXR); and Xpert MTB/RIF.

What are the main results in this review?

Nineteen studies assessed the following screening tests: one symptom (15 studies, 10,097 participants); more than one symptom (12 studies, 29,889 participants); CXR (10 studies, 7146 participants); and Xpert MTB/RIF (two studies, 787 participants).

Symptom screening

For every 1000 children screened, if 50 had tuberculosis according to the reference standard:

One or more of cough, fever, or poor weight gain in tuberculosis contacts (composite reference standard (CRS) (4 studies)

– 339 would screen positive, of whom 294 (87%) would not have tuberculosis (false positive).

– 661 would screen negative, of whom 5 (1%) would have tuberculosis (false negative).

One or more of cough, fever, or decreased playfulness in children under five, inpatient or outpatient (CRS) (3 studies)

– 251 to 636 would screen positive, of whom 219 to 598 (87% to 94%) would not have tuberculosis (false positive).

– 364 to 749 would screen negative, of whom 12 to 18 (2% to 3%) would have tuberculosis (false negative).

One or more of cough, fever, poor weight gain, or tuberculosis close contact (WHO four‐symptom screen) in children with HIV, outpatient (CRS) (2 studies)

– 88 would screen positive, of which 57 (65%) would not have tuberculosis (false positive).

– 912 would screen negative, of which 19 (2%) would have tuberculosis (false negative).

Abnormal CXR in tuberculosis contacts (CRS) (8 studies)

– 63 would screen positive, of whom 19 (30%) would not have tuberculosis (false positive).

– 937 would screen negative, of whom 6 (1%) would have tuberculosis (false negative).

Xpert MTB/RIF in children, inpatient or outpatient microbiologic reference standard (MRS) (2 studies)

– 31 to 69 would be Xpert MTB/RIF‐positive, of whom 9 to 19 (28% to 29%) would not have tuberculosis (false positive).

– 969 to 931 would be Xpert MTB/RIF‐negative, of whom 0 to 28 (0% to 3%) would have tuberculosis (false negative).

How reliable are the results of the studies in this review?

Diagnosing tuberculosis in children is difficult. This may lead to screening tests appearing more or less accurate than they actually are. For Xpert MTB/RIF, there were few studies and children tested to be confident about results.

Who do the results of this review apply to?

Children at risk for pulmonary tuberculosis. Results likely do not apply to children in the general population. Studies mainly took place in countries with a high burden of tuberculosis.

What are the implications of this review?

In children who are tuberculosis contacts or living with HIV, screening tests using symptoms or CXR may be useful. However, symptoms and CXR formed part of the reference standard, which may falsely elevate the accuracy of the results. We urgently need better screening tests for tuberculosis in children to better identify children who should be considered for tuberculosis preventive treatment and to increase the timeliness of treatment in those with tuberculosis disease.

How up‐to‐date is this review?

To 14 February 2020.

Read the full Cochrane Review here:

Comment

Sign up to add a comment

More about this case

Unresolved

Why you should join Figure 1

Sign up to explore now

Similar cases

\ \ In people with mild cognitive impairment (MCI), does using a 18F PET scan with florbetapir predict the progression to Alzheimer's disease dementia (ADD) and other dementias?\ Cochrane Review; 3 studies (453 participants with MCI).\ Key findings:\ At follow-up of 1.6 years, the scan correctly classified 89% of the participants who progressed to ADD but only 58% of the participants who did not progress to ADD. This means that in a group of 100 people with MCI, 15% of whom will develop ADD, we would expect 13 of 15 people to have a positive result and the other 2 participants to be falsely negative. Also 49 people who will not develop ADD would have a negative result, but 36 people who will not develop ADD would have a positive result (false positives).\ In a study that followed up people for 3 years, the scan correctly classified 67% of people who progressed to ADD and 71% who did not progress to ADD. This means in a group of 100 people with MCI, 19 of whom will develop ADD, we would expect 13 people to have a positive result of the scan and 6 people to have a falsely negative result. Also 58 of 81 participants who will not progress to ADD would have a negative result, but 23 people who will not develop ADD would have a positive result (false positives).\ That 18F-florbetapir PET scans cannot be recommended for routine clinical use based on the currently available data.](https://app.figure1.com/case-detail/14410ac0-c2c3-4a98-8045-31e53655c337)

\ \ Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV‐positive individuals\ Why is improving tuberculosis diagnosis in people with HIV important?\ Diagnosing active tuberculosis in people living with HIV is challenging. People with advanced immunosuppression have high rates of extrapulmonary tuberculosis (tuberculosis outside the lungs).\ What is the aim of this review?\ The aim of this review is to find out how accurate an ultrasound examination of the abdomen (abdominal ultrasound) is for diagnosing tuberculosis in people with HIV suspected of having tuberculosis in the abdomen or widespread tuberculosis (disseminated tuberculosis) involving the abdomen.\ What was studied in the review?\ Abdominal ultrasound can be done after other tests (e.g. the chest x‐ray did not indicate tuberculosis ) or it can be done before other tests in people suspected of having tuberculosis. This review focuses on situations where other tests are not available.\ What are the main results in this review?\ We found 11 studies, but only six were relevant for the main analyses. The six studies were divided into two groups. In the first group tuberculosis was diagnosed by identifying the organism causing tuberculosis from any specimen (microbiological confirmation). For the second group, tuberculosis was diagnosed when healthcare personnel suspected tuberculosis and started anti‐tuberculosis treatment, but without identifying the organism (clinical diagnosis). Three studies provided results for both groups.\ The review included five studies (a total of 879 participants) with microbiological confirmation. The results showed that if abdominal ultrasound were to be used in a group of 1000 people with HIV where 200 (20%) have tuberculosis then:\ ‐ About 382 individuals would have an ultrasound result indicating tuberculosis; of these, 256 (67%) would be incorrectly classified as having tuberculosis (false positives).\ ‐ Of the 618 individuals with a result indicating that tuberculosis is not present, 74 (12%) would be incorrectly classified as not having tuberculosis (false negatives).\ How reliable are the results of the studies in this review?\ Microbiological confirmation is likely to be a reliable method for deciding whether people really have tuberculosis; clinical diagnosis is likely to be less trustworthy. We found problems in both groups with how studies were conducted. Decreasing the number of false positive results may make abdominal ultrasound appear more accurate than it is. Numbers shown are an average across studies. As estimates from individual studies varied, we cannot be sure that abdominal ultrasound will always produce these results. Not enough people have been studied for us to be confident about the results.\ Who do the results of the review apply to?\ Studies included in the main analyses were done in Cambodia, India, South Africa, South Sudan, Spain, and Tanzania. Reasons for including people differed between the studies. Four studies used trained radiologists (specialists) or sonographers; two used doctors trained in ultrasound (non‐specialists), and two included people without any suspicion of tuberculosis. Across the studies, the percentage of people with a final diagnosis of tuberculosis ranged from 18% to 64%.\ What are the implications of this review?\ If the test is used to rule in the disease in the absence of other evidence, then, the chance of diagnosing someone with tuberculosis when they actually do not have it is high. Chances of missing a diagnosis of tuberculosis when the test is positive are lower, but a negative test alone is probably insufficient to rule out the disease. These findings should be considered when deciding whether or not to use abdominal ultrasound to test for tuberculosis involving the abdomen and how to interpret the results in the context of other clinical and diagnostic test information.\ How up‐to‐date is this review?\ The review authors searched for studies up to 4 April 2019.](https://app.figure1.com/case-detail/1c36f842-8ea0-401b-9b64-452a5c7c2458)

\ \ In people with mild cognitive impairment (MCI), does using a 18F PET scan with florbetaben predict progression to Alzheimer's disease dementia (ADD) and other dementias?\ Cochrane Review; 1 study (45 participants with MCI); funded by the test manufacturer.\ Key findings:\ Based on only one study, the 18F-florbetaben PET scan, as a single test with visual assessment, correctly classified 100% of the participants who will progress to ADD and 83% of the participants who did not progress to ADD at four years follow-up. This means in a cohort with 100 participants with MCI, 47 of whom will progress to ADD, we would expect that all those 47 MCI participants would test positive with the 18F-florbetaben scan and that 0 participants would be falsely negative (i.e. none of the 47 participants would have a negative test and yet progress to ADD). In addition, we would expect 44 of 53 participants who did not progress to ADD to be 18F-florbetaben-negative and 9 to be falsely positive (i.e. 9 of the 53 participants would have a positive test but not progress to ADD).\ The small size of the included study lowered our confidence on these estimates of accuracy. It is possible that the test is considerably less accurate than these results suggest.\ 18F-florbetaben imaging is a promising test to predict the progression from MCI to ADD; but more studies are needed.](https://app.figure1.com/case-detail/36d33887-e9d8-4647-be17-a59e554efe03)

\ \ Why is improving the diagnosis of pulmonary tuberculosis important?\ In 2018, at least one million children became ill with tuberculosis and around 200,000 died. When detected early and effectively treated, tuberculosis is largely curable. Xpert MTB/RIF and Xpert Ultra are World Health Organization‐recommended tests that simultaneously detect tuberculosis and rifampicin resistance in adults and children with tuberculosis symptoms. Rifampicin is an important anti‐tuberculosis drug. Not recognizing tuberculosis early may result in delayed diagnosis and treatment, severe illness, and death. A false tuberculosis diagnosis may result in anxiety and unnecessary treatment.\ What is the aim of this review?\ To determine the accuracy of tests in symptomatic children for diagnosing pulmonary tuberculosis, tuberculous meningitis, lymph node tuberculosis, and rifampicin resistance.\ What was studied in this review?\ Xpert MTB/RIF and Xpert Ultra, with results measured against culture and a composite reference standard (benchmarks), recognizing that neither reference is perfect in children.\ What are the main results in this review?\ A total of 49 studies were included. For pulmonary tuberculosis, we analysed 299 data sets including information describing nearly 70,000 children.](https://app.figure1.com/case-detail/370da24f-1d83-4cde-be75-569d879068a7)

Trending now

\ \ A 52-year-old man presented with a 20-minute history of chest pain radiating to the left shoulder and neck, associated with dyspnea and diaphoresis.\ He had a history of hypertension, long-term smoking, and a sedentary lifestyle.\ On physical examination, bibasilar crackles were noted on lung auscultation. An electrocardiogram (ECG) was performed in the primary care setting, and the patient was promptly referred to the emergency department.](https://app.figure1.com/case-detail/ae0fe999-6875-4474-94f0-ad823dbb9b3a)

\ \ A 28-year-old woman presented with a 3-day history of intense pruritus over the lower back. She reported no recent travel or exposure to new environments. She cares for a small kennel with approximately eight dogs rescued from the streets.\ Physical examination revealed multiple small vesicles, some clustered and others scattered, predominantly involving the lumbar region and the left gluteal area.](https://app.figure1.com/case-detail/c271070f-2bc7-4052-9895-635277e1a7d5)

\ \ A 4-month-old male infant presented with skin lesions localized to the chin for the past 3 days. Physical examination revealed multiple small pustules with surrounding inflammatory signs on the chin, along with a few scattered papules on the chest.](https://app.figure1.com/case-detail/48f41642-b9db-4089-b120-a94ee52328de)

\ \ patient in late teens presenting after a collapse, no chest pain, no previous cardiac history, no history of sudden death in family, are there any features in this ekg that would warrant further work-up or is this just a pediatric ekg?](https://app.figure1.com/case-detail/2af390e1-ace8-40ed-ba1c-98fb2d72f4c5)